ArticleZoonoses and public health2026
Crimean-Congo Haemorrhagic Fever Virus Exposure in Horses and Donkeys in Border Livestock Markets of Nigeria.
Article in Zoonoses and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
introductionCrimean-Congo haemorrhagic fever virus (CCHFV) is a tick-borne zoonotic pathogen of major public health importance in Africa. Although CCHFV exposure has been reported in several livestock species in Nigeria, data on equids remain limited despite their extensive involvement in livestock movement and trade. This study assessed CCHFV seroprevalence in horses and donkeys in major international livestock markets in northern Nigeria and examined factors associated with exposure.
methodsFrom June 2023 to July 2024, a longitudinal sero-surveillance study was conducted in three high-volume livestock markets in northern Nigeria. Serum samples from 808 equids (305 horses and 503 donkeys) were tested for CCHFV-specific IgG antibodies using a commercial multi-species ELISA. Data on age, sex, origin and tick infestation status were collected. Seroprevalence was estimated with 95% confidence intervals, and associations were evaluated using univariable analyses and multilevel binomial logistic regression accounting for market-state clustering.
resultsOverall CCHFV seroprevalence was 23.1% (95% CI: 20.3%-26.2%). Horses had a significantly higher seroprevalence (52.1%, 95% CI: 46.3%-58.0%) than donkeys (5.7%, 95% CI: 3.7%-8.1%) (p < 0.001). In univariable analyses, seropositivity in horses was associated with age and sex, whereas no significant associations were observed in donkeys. In the multilevel model, species and age remained independently associated with seropositivity; horses had substantially higher odds than donkeys (OR = 20.91, 95% CI: 11.14-39.24), and odds increased with age (OR = 1.17 per year, 95% CI: 1.06-1.29).
conclusionsCCHFV exposure is widespread among equids in northern Nigeria, particularly in horses. These findings support the potential value of horses as sentinel species for CCHFV surveillance in livestock trade corridors. SUMMARY: Crimean-Congo haemorrhagic fever virus (CCHFV) is a tick-borne zoonotic virus of public health importance in Africa, yet data on equids in Nigeria remain limited. We assessed CCHFV seroprevalence in horses and donkeys sampled at major international livestock markets in northern Nigeria. Serum samples from 808 equids were tested using a commercial multi-species ELISA. Overall seroprevalence was 23.1% (95% CI: 20.3%-26.2%), with higher seroprevalence in horses (52.1%) than in donkeys (5.7%). In multilevel analyses, species and age were independently associated with seropositivity, while sex, tick infestation status and animal origin were not. These findings indicate widespread CCHFV exposure among equids and suggest that horses may serve as useful sentinel animals for monitoring CCHFV circulation in livestock trade corridors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.